featured
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage ALS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
JAMA Neurol 2022 Jun 01;79(6)575-583, R Oki, Y Izumi, K Fujita, R Miyamoto, H Nodera, Y Sato, S Sakaguchi, H Nokihara, K Kanai, T Tsunemi, N Hattori, Y Hatanaka, M Sonoo, N Atsuta, G Sobue, T Shimizu, K Shibuya, K Ikeda, O Kano, K Nishinaka, Y Kojima, M Oda, K Komai, H Kikuchi, N Kohara, M Urushitani, Y Nakayama, H Ito, M Nagai, K Nishiyama, D Kuzume, S Shimohama, T Shimohata, K Abe, T Ishihara, O Onodera, S Isose, N Araki, M Morita, K Noda, T Toda, H Maruyama, H Furuya, S Teramukai, T Kagimura, K Noma, H Yanagawa, S Kuwabara, R KajiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.